Dificid Approval History
FDA Approved: Yes (First approved May 27, 2011)
Brand name: Dificid
Generic name: fidaxomicin
Company: Optimer Pharmaceuticals, Inc.
Treatment for: Clostridial Infection
Dificid (fidaxomicin) is a macrolide antibacterial drug indicated for the treatment of Clostridium difficile-associated diarrhea.
Development History and FDA Approval Process for Dificid
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.